Deb Hart | Head of Investor Relations |
Carl Hull | Chief Executive Officer |
Kevin Herde | Executive Vice President and Chief Financial Officer |
Brandon Couillard | Jefferies |
Yuko Oku | Morgan Stanley |
Paul Knight | KeyBanc Capital Markets |
Matt Larew | William Blair |
Catherine Schulte | Baird |
Michael Ryskin | Bank of America Merrill Lynch |
John Sourbeer | UBS |
Good day, and thank you for standing by. Welcome to the Q3 2021 Maravai LifeSciences Fourth Quarter 2021 Earnings Conference Call. [Operator instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to Ms. Deb Hart, Head of Investor Relations.